DE3850593T2 - Synthetische Antigene zur Bestimmung der AIDS-bezogenen, von LAV-2 verursachten Krankheiten. - Google Patents

Synthetische Antigene zur Bestimmung der AIDS-bezogenen, von LAV-2 verursachten Krankheiten.

Info

Publication number
DE3850593T2
DE3850593T2 DE3850593T DE3850593T DE3850593T2 DE 3850593 T2 DE3850593 T2 DE 3850593T2 DE 3850593 T DE3850593 T DE 3850593T DE 3850593 T DE3850593 T DE 3850593T DE 3850593 T2 DE3850593 T2 DE 3850593T2
Authority
DE
Germany
Prior art keywords
lav
aids
determination
related diseases
diseases caused
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3850593T
Other languages
English (en)
Other versions
DE3850593D1 (de
DE3850593T3 (de
Inventor
Wesley L Cosand
Andrew J Watson
Raymond L Houghton
Luc Montagnier
Marc Alizon
Solange Chamaret
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Genetic Systems Corp
Original Assignee
Institut Pasteur de Lille
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26706000&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3850593(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Institut Pasteur de Lille, Genetic Systems Corp filed Critical Institut Pasteur de Lille
Publication of DE3850593D1 publication Critical patent/DE3850593D1/de
Publication of DE3850593T2 publication Critical patent/DE3850593T2/de
Application granted granted Critical
Publication of DE3850593T3 publication Critical patent/DE3850593T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE3850593T 1987-03-25 1988-03-24 Synthetische Antigene zur Bestimmung der AIDS-bezogenen, von LAV-2 verursachten Krankheiten. Expired - Lifetime DE3850593T3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3040387A 1987-03-25 1987-03-25
US3540887A 1987-04-07 1987-04-07

Publications (3)

Publication Number Publication Date
DE3850593D1 DE3850593D1 (de) 1994-08-18
DE3850593T2 true DE3850593T2 (de) 1994-12-15
DE3850593T3 DE3850593T3 (de) 2001-01-04

Family

ID=26706000

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3850593T Expired - Lifetime DE3850593T3 (de) 1987-03-25 1988-03-24 Synthetische Antigene zur Bestimmung der AIDS-bezogenen, von LAV-2 verursachten Krankheiten.

Country Status (6)

Country Link
EP (1) EP0284383B2 (de)
AT (1) ATE108457T1 (de)
CA (1) CA1341436C (de)
DE (1) DE3850593T3 (de)
ES (1) ES2058259T5 (de)
GR (1) GR3033885T3 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8701628D0 (sv) * 1987-04-16 1987-04-16 Erling Norrby Medel for analys mm
US5780038A (en) * 1987-11-16 1998-07-14 Roche Diagnostic Systems, Inc. HIV-2 envelope polypeptides
DE3879881D1 (de) * 1987-11-16 1993-05-06 Hoffmann La Roche Rekombinante hiv-2 polypeptide.
EP0362927A3 (de) * 1988-10-06 1990-11-14 Akzo N.V. Mit HIV-Antikörpern immunochemisch reaktive synthetische Polypeptide
GB8828098D0 (en) * 1988-12-01 1989-01-05 Wellcome Found Peptides
GB8828097D0 (en) * 1988-12-01 1989-01-05 Wellcome Found Peptides
GB8910145D0 (en) * 1989-05-03 1989-06-21 Connaught Lab Synthetic peptides for an hiv-1 vaccine
CA2017021A1 (en) * 1989-05-22 1990-11-22 Johannes Jacobus Schalken Diagnostic test for detecting antibodies directed against antigens of one or more related viruses
EP0438332B1 (de) * 1990-01-16 1998-04-08 Orgenics Ltd. Peptide, von Virus-HIV-Hüllen-Glycoproteinen abstammend, deren Verwendung zum Nachweis einer Infektion dieser Viren und für die Impfung gegen AIDS
FR2657016B1 (fr) * 1990-01-16 1995-08-25 Clonatec Sa Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-2, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
DE3650175T3 (de) * 1985-04-29 2007-09-06 Bio-Rad Laboratories, Inc., Hercules Synthetische antigene zum nachweis von aids.
JP2702911B2 (ja) * 1985-09-11 1998-01-26 ユナイテツド・バイオメデイカル・インコ−ポレ−テツド 合成ペプチド、並びにそれを用いたエイズおよびプリ・エイズの検出方法
FR2593190B1 (fr) * 1986-01-22 1989-10-20 Pasteur Institut Nouveau retrovirus susceptible de provoquer le sida, antigenes obtenus a partir de ce retrovirus et anticorps correspondants et leurs applications au diagnostic du sida

Also Published As

Publication number Publication date
EP0284383A1 (de) 1988-09-28
DE3850593D1 (de) 1994-08-18
EP0284383B1 (de) 1994-07-13
CA1341436C (en) 2003-08-05
DE3850593T3 (de) 2001-01-04
EP0284383B2 (de) 2000-04-05
ATE108457T1 (de) 1994-07-15
GR3033885T3 (en) 2000-11-30
ES2058259T5 (es) 2000-09-01
ES2058259T3 (es) 1994-11-01

Similar Documents

Publication Publication Date Title
DK268588A (da) Syntetisk peptidantigen til detektering af hiv-2-infektion
ATE116006T1 (de) Synthetische antigene zum nachweis von aids.
DK0891982T3 (da) HIV-peptider
ATE107663T1 (de) Synthetische peptidantigene zum nachweis von htlv-1-infektionen.
DK0787191T4 (da) Nukleotidsekvenser af HIV-1 type (eller undertype) O retrovirusantigener
NO881151L (no) Syntetisk hiv-1-antigen.
NO173958C (no) Fremgangsmaate for paavisning av tilstedevaerelse av antistoff mot HIV-virus
DE3850593T3 (de) Synthetische Antigene zur Bestimmung der AIDS-bezogenen, von LAV-2 verursachten Krankheiten.
DE69013950T2 (de) Monoklonaler Antikörper zur Unterscheidung HIV-2-seropositiver von HIV-1-seropositiven Individuen.
ATE128716T1 (de) Hiv-peptide und methoden für den nachweis von hiv.
DE69028561T2 (de) Immunoassay zum Nachweis von Antikörpern gegen HIV
ATE467690T1 (de) Synthetisches antigen zum nachweis von hiv- immunreaktiven antikörpern
ES2009280A6 (es) Un metodo para detectar anticuerpos al virus hiv-1 en una muestra.
ES2129358A1 (es) Procedimiento de deteccion en una sola prueba de anticuerpos anti-virus de la hepatitis c, de la inmunodeficiencia humano y antigeno de superficie del virus de la hepatitis b".

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings